Business · 12/07/2011
FDA Releases Draft Guidance on Premarket Notification Requirements for In Vitro Diagnostic and Radiology Devices
The Food and Drug Administration (FDA) has made available a draft guidance outlining its enforcement policy for premarket notification requirements for certain in vitro diagnostic and radiology devices, which are now available for public review and comment.
Original source language: Federal Register — Health and Human ServicesOpen original release →